| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |